Histidine

Histidine

SCHEMBL5491751

NC1CCCCC1.N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.74
▸ SLC7A5 Q01650 1/20 0.74
▸ DPP4 P27487 1/20 0.52
▸ CPB2 Q96IY4 2/20 0.47
▸ DPP7 Q9UHL4 1/20 0.46
▸ HRH4 Q9H3N8 3/20 0.46
▸ PPM1B O75688 2/20 0.46
▸ HTR3A P46098 1/20 0.46
▸ EPHX2 P34913 1/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ THPO P40225 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL137600 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL388560 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL3260 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL19974306 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL30852263 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL28071764 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
D-Histidine SCHEMBL288043 0.86 CYP3A4 (1.00) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL25362582 0.84 CYP3A4 (0.97) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL23002334 0.84 CYP3A4 (0.97) CYP3A4SLC7A5CPB2HRH4HRH3
Histidine SCHEMBL25267810 0.84 CYP3A4 (0.97) CYP3A4SLC7A5CPB2HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858538-A2 MUCIN HYPERSECRETION INHIBITORS BASED ON THE STRUCTURE OF MANS AND METHODS OF USE Biomarck Pharmaceuticals, Ltd. (US) 2007-11-28 — — EP disclosed
WO-2006078899-A2 MUCIN HYPERSECRETION INHIBITORS BASED ON THE STRUCTURE OF MANS AND METHODS OF USE BIOMARCK PHARMACEUTICALS, LTD. (US) 2006-07-27 — — WO disclosed
Send feedback